AUPH Aurinia Pharma: Forvard P/S multiplikatori

Aurinia Pharmaceuticals (AUPH) korporativ emblemasi va logotipi

Aksiyadorlarning rahbariyatga nisbatan shubhalari va birlashishlarning yo'qligini hisobga olgan holda, Aurinia Pharmaceuticals (AUPH) kompaniyasiga investitsiya kiritishga arziydimi? Aurinia Pharmaceuticals (AUPH) uchun ushbu forward P/S grafigi kutishlar tendentsiyasini aks ettiradi, bunda 13.10 darajasi joriy qiymatni ifodalaydi. Biznes Lonza orqali ishlab chiqarishni autsorsing qilishga tayanadi, bu esa dori ishlab chiqarishni logistikaga bog'liq qiladi. Yakuniy xulosada, Aurinia Pharmaceuticals (AUPH) nefrologlar tomonidan chuqur hurmat qilinadigan, maqsadli terapiyaning nufuzli ishlab chiquvchisi bo'lib qolmoqda.

AUPH (Aurinia Pharmaceuticals Inc.) Forvard P/S multiplikatori tarixi 04.07.2022dan 17.11.2026gacha

Aurinia Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:Aurinia Corp AUPH
Aurinia Pharmaceuticals tovar namunasi

Aktivning adolatli qiymatini baholash bozor narxining kutilayotgan daromadlar nisbatiga asoslangan. Ushbu ko'rsatkich joriy kapitalizatsiyani bir yillik tushum prognozi bilan solishtirib, kelajakdagi sotuvlarning har bir dollari qiymatini aniqlaydi. Forward P/S nisbatini tahlil qilish orqali investor qimmatli qog'ozning haddan tashqari sotib olingani yoki qadrsizlanganini aniqlaydi. Aurinia Pharmaceuticals (AUPH) uchun ushbu koeffitsientning o'sishi geosiyosiy risklar va sanksiyalar ostidagi zonalarda klinik sinovlarning to'xtashi bilan cheklanishi mumkin.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|Narxning prognoz qilingan daromadga nisbati Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati CLDX (Celldex Therapeutics)|Narxning prognoz qilingan daromadga nisbati BioCryst Pharmaceuticals BCRX|Sotuvga nisbatan forvard narx VERA|Dianthus Pharma - Forvard P/S multiplikatori|PHVS - Forvard P/S multiplikatori|ABCL: Forvard P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Intrexon|PHAR - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori NKTR|Narxning prognoz qilingan daromadga nisbati UPB (Upstream Bio Corp)|Narxning prognoz qilingan daromadga nisbati Zenas Biopharma, Inc. ZBIO|Kapitalizatsiyaning kutilayotgan sotuvga nisbati immunome.com (IMNM)|Gossamer Bio Inc - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pieris Pharmaceuticals Inc|Forvard narx/daromad multiplikatori SVRA|Forvard narx/daromad multiplikatori Rigel Pharmaceuticals (RIGL)|Forvard P/S multiplikatori ANAB|ATXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati enGene Corp ENGN|Kapitalizatsiyaning kutilayotgan sotuvga nisbati RAPT Therapeutics, Inc. (RAPT)|Aerovate - Forvard P/S multiplikatori|ACRS - Forvard P/S multiplikatori|KYTX (Kyverna Therapeutics) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Tiziana Life Sciences Ltd. (TLSA)|Forvard narx/daromad multiplikatori CABA|Ventyx Biosciences (VTYX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ELDN (eledon.com)|AGEN - Forvard narx/daromad multiplikatori|CLYM - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ZURA|ATYR: Forvard P/S multiplikatori|Adagene Corp (ADAG) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori IMA|Shattuck Labs, Inc. - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Equillium Inc (EQ)|Forvard P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning prognoz qilingan daromadga nisbati Immunic, Inc. IMUX|Forvard P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning prognoz qilingan daromadga nisbati|XFOR: Narxning prognoz qilingan daromadga nisbati|ACET: Forvard P/S multiplikatori|CELU - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati inmunebio.com|Kapitalizatsiyaning prognoz qilingan daromadga nisbati BRNS (barinthusbio.com)|Forvard P/S multiplikatori KZR|Forvard P/S multiplikatori SAB Biotherapeutics, Inc (SABS)|Forvard P/S multiplikatori AKTX (Akari Therapeutics, Plc)|Forvard P/S multiplikatori enlivex.com ENLV|QTTB: Forvard narx/daromad multiplikatori|GOVX - Forvard P/S multiplikatori|Edesa Biotech Inc (EDSA) - Narxning prognoz qilingan daromadga nisbati|IBIO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati carismatx.com|XTLB: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati aptevotherapeutics.com APVO|AIM - Forvard narx/daromad multiplikatori|Aditxt - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Corporation GRI|xortx.com (XRTX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati reshapelifesciences.com (HIND)|Narxning prognoz qilingan daromadga nisbati Revelation Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Indaptus Therapeutics, Inc. INDP|Narxning prognoz qilingan daromadga nisbati BiondVax Pharmaceuticals (SCNI)|Forvard narx/daromad multiplikatori CalciMedica CALI|Narxning prognoz qilingan daromadga nisbati Affimed AFMD|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA Pharma, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com